| Literature DB >> 34193664 |
Jayathilake Sarangi1, Nao Matsuo2, Rina Nonogaki2, Michiko Hayashi2, Kumiko Kawamura2, Masahiro Suzuki3, Wanchun Jin1, Kiyoko Tamai4, Miho Ogawa5, Jun-Ichi Wachino1, Kouji Kimura1, Tetsuya Yagi6, Yoshichika Arakawa1,7.
Abstract
The Enterobacter cloacae complex (ECC) is one of the most common causes of bacteremia and leads to poor clinical outcomes. The aim of this study was to clarify the antimicrobial susceptibility profiles and genetic backgrounds of non-carbapenemase-producing reduced-carbapenem-susceptible (RCS) ECC blood isolates in Japan using agar dilution antimicrobial susceptibility testing, whole-genome sequencing, and quantitative polymerase chain reaction for ampC, ompC, and ompF transcripts. Forty-two ECC blood isolates were categorized into RCS and carbapenem-susceptible groups based on the minimum inhibitory concentration of imipenem. The RCS ECC blood isolates belonged to distinct species and sequence types and produced varying class C β-lactamases. The E. roggenkampii, E. asburiae, and E. bugandensis isolates belonged only to the RCS group. Some E. hormaechei ssp. steigerwaltii isolates from the RCS group exhibited AmpC overexpression caused by amino acid substitutions in AmpD and AmpR along with ompF downregulation. These findings suggest that non-carbapenemase-producing RCS ECC blood isolates are genetically diverse.Entities:
Keywords: Carbapenem-resistant Enterobacteriaceae; Enterobacter cloacae complex; Enterobacter roggenkampii; bacteremia; whole-genome sequencing
Mesh:
Substances:
Year: 2021 PMID: 34193664 DOI: 10.7883/yoken.JJID.2021.141
Source DB: PubMed Journal: Jpn J Infect Dis ISSN: 1344-6304 Impact factor: 1.362